Market revenue in 2023 | USD 883.4 million |
Market revenue in 2030 | USD 1,716.8 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical industry |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro toxicology testing market will help companies and investors design strategic landscapes.
Pharmaceutical industry was the largest segment with a revenue share of 43.24% in 2023. Horizon Databook has segmented the Spain in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
The in-vitro toxicology testing market in Spain is competitive owing to the presence of a blend of public as well as private companies. Some of the key players dominating Spain in-vitro toxicology testing market are SGS S.A. and Eurofins Scientific.
Moreover, robust support for research activities across Europe, including Spain, is likely to provide growth opportunities for market growth. For instance, in September 2022, an EU-funded project REMEDi4ALL was launched to develop and screen novel therapeutic approaches in the European Union. This initiative also combined the expertise of in vitro-driven drug repurposing programs and in-silico platforms.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain in-vitro toxicology testing market , including forecasts for subscribers. This country databook contains high-level insights into Spain in-vitro toxicology testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account